Holly Hagan

Strategic.
Medical.

Creative.

Pharmaceutical and Healthcare Advertising Specialist.

Seen In:

Hi! I'm Holly.

I'm a medical copywriter on a mission to educate and train agencies and creatives in pharma advertising.

After 14 years working with 15+ agencies on 60+ pharma brands, I offer customized services in these areas:

Holly Hagan is disrupting the status quo of the agency training model for medical / pharma copywriters.

—PM360 Magazine, ELITE 2024

Advertising Craft and Workflow Process

Training competent copywriters who can reach their potential takes time, effort, and consistency. I've packaged my 14+ years of professional experience into a medical copywriting training program that involves direct mentorship from me.

People from agencies in Canada, Europe, and the US have taken the program to accelerate their learning and improve their competencies in pharmaceutical advertising. A customizable program for agency teams is available.

Thanks for another great session! We found it very valuable.

—VP, Healthcare Strategy & Client Services

Regulatory Submissions of Advertising Material

Submitting advertising and promotional material to PAAB since 2009: From Canadianizing marketing assets to preparing submissions and responding to PAAB comments in writing and by phone. I can help your team manage one of the most challenging aspects of pharma advertising in Canada.

And if you want to understand the FDA submission process better, I can help you with that too.

Just a quick message to say Thank You again for your great program! I definitely got a lot from it and hope the others did as well.

—Associate Creative Director, Medical

Goal Achieving and Mindset Coaching for Teams

Explore the subconscious habits behind behaviour and identify beliefs that are standing in the way of the team's desired results. By understanding how the mind controls behaviour, we can replace unwanted habits and beliefs with new ones and create lasting change.

As a certified Khan Method Coach, I've been coaching teams and individuals since 2022.